BlueStem Wealth Partners LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

BlueStem Wealth Partners LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 1,016 shares of the medical equipment provider’s stock, valued at approximately $530,000.

A number of other institutional investors have also recently made changes to their positions in ISRG. Howard Capital Management Group LLC boosted its stake in shares of Intuitive Surgical by 4.5% in the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after acquiring an additional 92 shares during the last quarter. Pinnacle Associates Ltd. boosted its stake in shares of Intuitive Surgical by 2.1% in the third quarter. Pinnacle Associates Ltd. now owns 2,552 shares of the medical equipment provider’s stock worth $1,254,000 after acquiring an additional 53 shares during the last quarter. Focus Financial Network Inc. boosted its stake in shares of Intuitive Surgical by 14.4% in the third quarter. Focus Financial Network Inc. now owns 1,273 shares of the medical equipment provider’s stock worth $626,000 after acquiring an additional 160 shares during the last quarter. Americana Partners LLC boosted its stake in shares of Intuitive Surgical by 4.0% in the third quarter. Americana Partners LLC now owns 3,444 shares of the medical equipment provider’s stock worth $1,692,000 after acquiring an additional 131 shares during the last quarter. Finally, Capital Advisors Inc. OK boosted its stake in shares of Intuitive Surgical by 5.4% in the third quarter. Capital Advisors Inc. OK now owns 127,893 shares of the medical equipment provider’s stock worth $62,830,000 after acquiring an additional 6,522 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,077 shares of company stock worth $4,620,025 in the last quarter. 0.90% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Truist Financial boosted their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Royal Bank of Canada boosted their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, UBS Group boosted their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Trading Up 1.7 %

ISRG stock opened at $573.15 on Friday. The business’s fifty day moving average price is $569.87 and its 200 day moving average price is $529.06. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market capitalization of $204.14 billion, a PE ratio of 89.42, a P/E/G ratio of 5.85 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.